Johnson & Johnson (JNJ)
undefined
undefined%
At close: undefined
143.89
0.34%
Pre-market Jan 07, 2025, 06:45 AM EST

Johnson & Johnson Revenue Breakdown

Quarter Sep 29, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Oct 1, 2023Oct 3, 2010Jul 4, 2010
MedTech Revenue 7.89B 7.96B 7.82B 7.67B 7.46B 5.92B 6.13B
MedTech Revenue Growth -0.83% +1.74% +1.93% +2.88% +25.98% -3.43% n/a
INNOVATIVE MEDICINE Revenue 14.58B 14.49B 13.56B 13.72B 13.89B n/a n/a
INNOVATIVE MEDICINE Revenue Growth +0.62% +6.84% -1.17% -1.23% n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Jan 1, 2023Jan 2, 2022Jan 3, 2021Dec 29, 2019Dec 30, 2018Dec 31, 2017Jan 1, 2017Jan 3, 2016Dec 28, 2014Dec 29, 2013Dec 30, 2012Jan 1, 2012Jan 2, 2011
Asia-Pacific, Africa Revenue 13.76B 16.79B 17.27B 15.14B 15.55B 14.83B 13.42B 12.57B 12.35B 13.44B 13.38B 16.95B 17.13B 11.08B
Asia-Pacific, Africa Revenue Growth -18.07% -2.81% +14.13% -2.69% +4.88% +10.51% +6.72% +1.85% -8.15% +0.45% -21.03% -1.07% +54.64% n/a
Europe Revenue 20.41B 23.45B 23.59B 18.98B 18.47B 18.75B 17.13B 15.77B 15.99B 18.95B 18.60B 29.83B 28.91B 15.51B
Europe Revenue Growth -12.96% -0.61% +24.31% +2.78% -1.53% +9.50% +8.60% -1.41% -15.58% +1.87% -37.65% +3.19% +86.38% n/a
United States Revenue 46.44B 48.58B 47.16B 43.13B 42.10B 41.88B 39.86B 37.81B 35.69B 34.78B 31.91B n/a n/a 29.45B
United States Revenue Growth -4.40% +3.02% +9.33% +2.46% +0.51% +5.07% +5.43% +5.95% +2.60% +9.00% n/a n/a n/a n/a
Western Hemisphere, Excluding U.S. Revenue 4.55B 6.13B 5.75B 5.33B 5.94B 6.11B 6.04B 5.73B 6.04B 7.16B 7.42B n/a n/a n/a
Western Hemisphere, Excluding U.S. Revenue Growth -25.73% +6.52% +7.78% -10.20% -2.81% +1.19% +5.35% -5.14% -15.57% -3.52% n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 29, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Oct 1, 2023Jul 2, 2023Apr 2, 2023Jan 1, 2023Oct 2, 2022Jul 3, 2022Apr 3, 2022Jan 2, 2022Oct 3, 2021Jul 4, 2021Apr 4, 2021Jan 3, 2021Sep 27, 2020Jun 28, 2020Mar 29, 2020Dec 29, 2019Sep 29, 2019Jun 30, 2019Mar 31, 2019Dec 30, 2018Sep 30, 2018Jul 1, 2018Apr 1, 2018Dec 31, 2017Oct 1, 2017Jul 2, 2017Apr 2, 2017Jan 1, 2017Oct 2, 2016Jul 3, 2016Apr 3, 2016Jan 3, 2016Sep 27, 2015Jun 28, 2015Mar 29, 2015
Selling, General, and Administrative Revenue 5.28B 5.48B 5.06B 5.51B 5.10B 5.00B 4.51B 6.51B 4.97B 6.23B 5.64B 7.15B 6.00B 6.07B 5.43B 6.46B 5.43B 4.99B 5.20B 6.04B 5.37B 5.55B 5.22B 5.99B 5.54B 5.74B 5.26B 6.03B 5.42B 5.29B 4.76B 5.31B 4.77B 5.18B 4.69B 5.89B 5.08B 5.38B 4.85B
Selling, General, and Administrative Revenue Growth -3.70% +8.38% -8.22% +8.04% +2.08% +10.87% -30.80% +30.89% -20.09% +10.43% -21.19% +19.23% -1.20% +11.80% -15.87% +18.89% +8.77% -4.04% -13.84% +12.37% -3.10% +6.27% -12.89% +8.08% -3.48% +9.12% -12.65% +11.10% +2.53% +11.04% -10.28% +11.25% -7.81% +10.41% -20.42% +15.94% -5.63% +11.08% n/a
Research and Development Revenue 4.95B 3.44B 3.54B 4.48B 3.45B 3.70B 3.46B 4.62B 3.48B 3.70B 4.07B 4.72B 3.42B 3.39B 3.18B 4.03B 2.84B 2.71B 2.58B 3.23B 2.60B 2.67B 2.86B 3.22B 2.51B 2.64B 2.40B 3.63B 2.58B 2.30B 2.07B 2.64B 2.18B 2.26B 2.01B 2.86B 2.15B 2.13B 1.90B
Research and Development Revenue Growth +43.95% -2.88% -20.94% +29.97% -6.91% +7.18% -25.28% +32.68% -5.89% -9.06% -13.73% +37.93% +0.82% +6.80% -21.18% +41.97% +4.91% +4.92% -20.17% +24.36% -2.51% -6.72% -11.35% +28.55% -4.96% +9.78% -33.87% +40.62% +12.59% +10.92% -21.59% +21.21% -3.80% +12.47% -29.71% +32.96% +1.17% +12.11% n/a